Back to Journals » Lung Cancer: Targets and Therapy » Volume 14

ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia

Total article views   HTML views PDF downloads Totals
4,109 Dovepress* 3,345+ 90 3,435
PubMed Central* 764 218 982
Totals 4,109 308 4,417
*Since 7 July 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar